{"nct_id":"NCT03657160","title":"Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2019-02-06","start_date_type":"ACTUAL","primary_completion_date":"2022-02-07","primary_completion_date_type":"ACTUAL","completion_date":"2022-05-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}